Commerzbank Aktiengesellschaft FI Buys 3,846 Shares of Xylem Inc. (NYSE:XYL)

Commerzbank Aktiengesellschaft FI lifted its stake in Xylem Inc. (NYSE:XYLFree Report) by 4.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,634 shares of the industrial products company’s stock after buying an additional 3,846 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Xylem were worth $11,698,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. Swedbank AB boosted its stake in shares of Xylem by 22.8% in the third quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock valued at $403,953,000 after buying an additional 554,609 shares during the period. Mirova US LLC raised its position in Xylem by 2.0% during the second quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company’s stock valued at $254,526,000 after purchasing an additional 36,013 shares in the last quarter. DekaBank Deutsche Girozentrale raised its position in Xylem by 2.2% during the second quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company’s stock valued at $227,364,000 after purchasing an additional 36,601 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Xylem by 8.3% during the second quarter. Dimensional Fund Advisors LP now owns 1,474,033 shares of the industrial products company’s stock valued at $199,930,000 after purchasing an additional 113,571 shares in the last quarter. Finally, Sei Investments Co. raised its position in Xylem by 3.1% during the second quarter. Sei Investments Co. now owns 1,045,023 shares of the industrial products company’s stock valued at $141,736,000 after purchasing an additional 31,709 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Performance

NYSE XYL opened at $131.82 on Wednesday. The company has a market capitalization of $32.02 billion, a price-to-earnings ratio of 41.57, a PEG ratio of 2.36 and a beta of 1.04. Xylem Inc. has a twelve month low of $87.59 and a twelve month high of $146.08. The stock has a fifty day simple moving average of $133.77 and a 200 day simple moving average of $135.23. The company has a quick ratio of 1.33, a current ratio of 1.85 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. The business had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.14 billion. Xylem had a return on equity of 9.48% and a net margin of 9.11%. Xylem’s quarterly revenue was up 26.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.98 earnings per share. Sell-side analysts expect that Xylem Inc. will post 4.26 EPS for the current year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th were given a dividend of $0.36 per share. The ex-dividend date was Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a yield of 1.09%. Xylem’s dividend payout ratio (DPR) is currently 45.57%.

Wall Street Analysts Forecast Growth

XYL has been the subject of several research analyst reports. UBS Group initiated coverage on shares of Xylem in a research report on Tuesday, August 13th. They set a “buy” rating and a $165.00 price objective for the company. Stifel Nicolaus boosted their price objective on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Robert W. Baird boosted their price objective on shares of Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. TD Cowen restated a “hold” rating and set a $138.00 price objective on shares of Xylem in a research report on Tuesday, September 3rd. Finally, Royal Bank of Canada upped their price target on shares of Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a report on Wednesday, July 31st. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $149.67.

Read Our Latest Report on Xylem

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.